Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Systemic Sclerosis Associated Interstitial Lung Disease”

36 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 36 results

Testing effectiveness (Phase 2)Looking for participantsNCT06350110
What this trial is testing

Fourth-gen CAR T Cells Targeting BCMA/CD19 for Refractory Systemic Lupus Erythematosus (SLE)

Who this might be right for
Systemic Lupus ErythematosusLupus NephritisAutoimmune Diseases+6 more
Essen Biotech 75
Large-scale testing (Phase 3)WithdrawnNCT03726398
What this trial is testing

CompRehensive Phenotypic Characterization of Patients With Scleroderma-Associated ILD and PH

Who this might be right for
Interstitial Lung DiseaseSclerodermaPulmonary Hypertension
Franz Rischard, DO
Not applicableUnknownNCT05482607
What this trial is testing

Evaluation of HRCT Patterns in Systemic Sclerosis-associated Interstitial Lung Disease

Who this might be right for
Systemic SclerosisInterstitial Lung Disease
Central Hospital, Nancy, France 100
Testing effectiveness (Phase 2)Active Not RecruitingNCT05270668
What this trial is testing

Phase 2 Safety and Efficacy Study of Tulisokibart (MK-7240/PRA023) in Subjects With Systemic Sclerosis Associated With Interstitial Lung Disease (SSc-ILD) (MK-7240-007)

Who this might be right for
Diffuse Cutaneous Systemic SclerosisInterstitial Lung Disease
Prometheus Biosciences, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 154
Not applicableWithdrawnNCT05177471
What this trial is testing

Efficacy and Safety of JAK Inhibitors in Systemic Sclerosis-associated Interstitial Lung Disease

Who this might be right for
Systemic SclerosisInterstitial Lung Disease
Central Hospital, Nancy, France
Not applicableLooking for participantsNCT07723872
What this trial is testing

Finger Versus Earlobe Pulse Oximetry During the 6-Minute Walk Test in Interstitial Lung Disease

Who this might be right for
Interstitial Lung Disease (ILD)Idiopathic Pulmonary Fibrosis (IPF)Progressive Pulmonary Fibrosis+2 more
Hospital de Granollers 100
Not applicableUnknownNCT03840928
What this trial is testing

PatientSpot Formerly Known as ArthritisPower

Who this might be right for
Rheumatoid ArthritisAnkylosing SpondylitisFibromyalgia+61 more
Global Healthy Living Foundation 40,000
Large-scale testing (Phase 3)Study completedNCT02597933
What this trial is testing

A Trial to Compare Nintedanib With Placebo for Patients With Scleroderma Related Lung Fibrosis

Who this might be right for
Scleroderma, Systemic
Boehringer Ingelheim 580
Not applicableEnrolling By InvitationNCT06472362
What this trial is testing

Chest CT Biomarkers as Prognostic Predictors in SSc-ILD

Who this might be right for
Systemic Sclerosis
Royal Brompton & Harefield NHS Foundation Trust 1,000
Not applicableUnknownNCT05450276
What this trial is testing

Patient-Reported Outcome Study of Project ECHO for ILD

Who this might be right for
Interstitial Lung Disease
Pulmonary Care and Research Collaborative Limited 56
Not applicableLooking for participantsNCT01776398
What this trial is testing

Collection of Airway, Blood and/or Urine Specimens From Subjects for Research Studies

Who this might be right for
Chronic Obstructive Pulmonary Disease (COPD)SmokingSmoking Cessation+3 more
Weill Medical College of Cornell University 2,000
Large-scale testing (Phase 3)Study completedNCT01862926
What this trial is testing

Rituximab Versus Cyclophosphamide in Connective Tissue Disease-ILD

Who this might be right for
Interstitial Lung DiseaseSclerodermaIdiopathic Inflammatory Myositis+1 more
Royal Brompton & Harefield NHS Foundation Trust 104
Not applicableUnknownNCT05445817
What this trial is testing

Pulmonary Care and Research Collaborative Patient Registry

Who this might be right for
Interstitial Lung Disease
Pulmonary Care and Research Collaborative Limited 150
Large-scale testing (Phase 3)Looking for participantsNCT05878717
What this trial is testing

The Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease

Who this might be right for
Systemic Sclerosis Associated Interstitial Lung DiseaseScleroderma, Systemic
GlaxoSmithKline 300
Early research (Phase 1)Study completedNCT03675581
What this trial is testing

Test Whether Nintedanib Influences the Components of Birth-control Pills in Women With Systemic Sclerosis Associated Interstitial Lung Disease (SSc-ILD)

Who this might be right for
Scleroderma, Systemic
Boehringer Ingelheim 17
Large-scale testing (Phase 3)Study completedNCT01570764
What this trial is testing

Cyclophosphamide Systemic Sclerosis Associated Interstitial Lung Disease

Who this might be right for
Systemic SclerosisSclerodermaInterstitial Lung Disease+1 more
Assistance Publique - Hôpitaux de Paris 40
Not applicableUnknownNCT03858842
What this trial is testing

Non-interventional Study Describing Epidemiology, Prognosis and Patient Healthcare Costs in France, 2010-2017

Who this might be right for
Lung Diseases, InterstitialLung Disease With Systemic Sclerosis
Hospices Civils de Lyon 100
Testing effectiveness (Phase 2)Looking for participantsNCT05785065
What this trial is testing

Mycophenolate Mofetil in Systemic Sclerosis With Subclinical Interstitial Lung Disease

Who this might be right for
Systemic Sclerosis With Lung InvolvementSystemic SclerosisInterstitial Lung Disease
Centre hospitalier de l'Université de Montréal (CHUM) 35
Not applicableStudy completedNCT04325217
What this trial is testing

Post-marketing Surveillance on Long Term Use of Ofev Capsules in Systemic Scleroderma Associated Interstitial Lung Disease (SSc-ILD) in Japan

Who this might be right for
Lung Diseases, Interstitial
Boehringer Ingelheim 586
Testing effectiveness (Phase 2)Looking for participantsNCT06189495
What this trial is testing

A Randomized, Double-blind, Placebo-controlled Phase II Clinical Study to Evaluate the Safety, Tolerability, Efficacy, and Pharmacokinetic Profile of Genakumab Injection in Patients With Connective Tissue Disease-associated Interstitial Lung Disease

Who this might be right for
Systemic Sclerosis Associated Interstitial Lung DiseaseRheumatoid Arthritis Associated Interstitial Lung Disease (RA-ILD)Systemic Sclerosis Associated Interstitial Lung Disease (SSc-ILD)
Changchun GeneScience Pharmaceutical Co., Ltd.
Next Page
30